Company Description
Devax is developing medical devices that go with the flow. Its Axxess drug-eluting stent system is designed to treat vascular disease in...
Key Devax Financials
| Company Type | Private - NASDAQ (GM): DEVX Proposed Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2006 Sales (mil.) | $0.0 |
| 2006 Employees | 33 |
More Devax Financials (4 pages)
Competition
Competitive Landscape for Medical Supplies and Devices
Demand is driven by population demographics and advances in medical knowledge and technology. The profitability of individual companies depends on the ability to develop superior...
Read more about Devax's competition across multiple industries
Top Devax Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Devax Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| CEO and Director | Paul R. Buckman | Network | E-mail |
| EVP and CFO | Stephen L. Wilson | Network | E-mail |
| President, COO, and Director | Jeffrey H. (Jeff) Thiel | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.